Literature DB >> 33414473

Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis.

Qian Li1,2, Jun Wang1,3,4, Heba Islam5, Carsten Kirschning5, Hongzhou Lu2, Daniel Hoffmann4, Ulf Dittmer1, Mengji Lu6.   

Abstract

Host immune control plays a pivotal role in resolving primary hepatitis-B-virus (HBV) infections. The complex interaction between HBV and host immune cells, however, remains unclear. In this study, the transcriptional profiling of specimens from animals infected with woodchuck hepatitis virus (WHV) indicated TLR2 mRNA accumulation as most strongly impacted during WHV infection resolution as compared to other mRNAs. Analysis of blood transcriptional modules demonstrated that monocytes and B-cells were the predominantly activated cell types in animals that showed resolution of infection, which was similar to the response of TLR2-stimulated PBMCs. Further investigation of TLR2-stimulated B-cells pointed at interactions between activated TLR signaling, Akt-mTOR, and glucose metabolic pathways. Moreover, analysis of B-cells from Tlr2-/-, Trif-/-, Myd88-/-, and Trif/Myd88-/- mice challenged with HBV particles indicated B-cell function and glucose metabolism alterations is TLR2-MyD88-mTOR axis dependent. Overall, our study implicates B-cell TLR2 activation in HBV infection resolution.

Entities:  

Year:  2021        PMID: 33414473      PMCID: PMC7791069          DOI: 10.1038/s41419-020-03284-1

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  40 in total

1.  TLR1/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro.

Authors:  Jia Liu; Min Jiang; Zhiyong Ma; Kirsten K Dietze; Gennadiy Zelinskyy; Dongliang Yang; Ulf Dittmer; Joerg F Schlaak; Michael Roggendorf; Mengji Lu
Journal:  J Immunol       Date:  2013-11-13       Impact factor: 5.422

Review 2.  Metabolic Regulation of the Immune Humoral Response.

Authors:  Mark Boothby; Robert C Rickert
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 3.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

4.  Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.

Authors:  Ahmad Faisal Karim; Scott M Reba; Qing Li; W Henry Boom; Roxana E Rojas
Journal:  Eur J Immunol       Date:  2017-07-18       Impact factor: 5.532

5.  Transcriptomic analysis of the woodchuck model of chronic hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Yongmei Ji; A Leonardo Iniguez; Bruce Taillon; David C Swinney; Palanikumar Ravindran; Donavan T Cheng; Hans Bitter; Uri Lopatin; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

6.  Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.

Authors:  Anna D Kosinska; Leila Pishraft-Sabet; Weimin Wu; Zhong Fang; Marzena Lenart; Jieliang Chen; Kirsten K Dietze; Cong Wang; Thekla Kemper; Yong Lin; Shiou-Hwei Yeh; Jia Liu; Ulf Dittmer; Zhenghong Yuan; Michael Roggendorf; Mengji Lu
Journal:  Hepatology       Date:  2017-05-26       Impact factor: 17.425

7.  The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model.

Authors:  Zhiyong Ma; Jia Liu; Weimin Wu; Ejuan Zhang; Xiaoyong Zhang; Qian Li; Gennadiy Zelinskyy; Jan Buer; Ulf Dittmer; Carsten J Kirschning; Mengji Lu
Journal:  Cell Mol Immunol       Date:  2017-07-31       Impact factor: 11.530

8.  Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity.

Authors:  Katell Bidet; Victor Ho; Collins Wenhan Chu; Ahmad Nazri Hohamed Naim; Khaing Thazin; Kuan Rong Chan; Jenny G H Low; Milly M Choy; Lan Hiong Wong; Paola Florez de Sessions; Yie Hou Lee; Martin L Hibberd; Eng Eong Ooi; Katja Fink; Jianzhu Chen
Journal:  NPJ Vaccines       Date:  2019-06-25       Impact factor: 7.344

Review 9.  Toward a Functional Cure for Hepatitis B: The Rationale and Challenges for Therapeutic Targeting of the B Cell Immune Response.

Authors:  Zhiyong Ma; Ejuan Zhang; Shicheng Gao; Yong Xiong; Mengji Lu
Journal:  Front Immunol       Date:  2019-09-24       Impact factor: 7.561

10.  Combinatorial signaling through TLR-2 and CD86 augments activation and differentiation of resting B cells.

Authors:  Shweta Jain; Sathi Babu Chodisetti; Javed N Agrewala
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more
  3 in total

Review 1.  Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection.

Authors:  Hongjuan You; Suping Qin; Fulong Zhang; Wei Hu; Xiaocui Li; Dongsheng Liu; Fanyun Kong; Xiucheng Pan; Kuiyang Zheng; Renxian Tang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 2.  Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.

Authors:  Yanqin Du; Jun Wu; Jia Liu; Xin Zheng; Dongliang Yang; Mengji Lu
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

Review 3.  Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Manasa Suresh; Stephan Menne
Journal:  Viruses       Date:  2022-08-03       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.